Goodwin Procter advised ACELYRIN on the deal. ACELYRIN announced the completion of its $300 million Series C financing round which was led by Access Biotechnology with participation...
You must be a Standard 1 Year member to access this content.
Sidley Austin LLP advised Clearlake Capital Group, L.P. on the deal. Confluence Technologies, Inc., a global software and data solutions provider helping the investment management industry...
You must be a Standard 1 Year member to access this content.
Sidley Austin LLP advised the lead investors on the deal. HBM Healthcare Investments, Cormorant Asset Management, and Octagon Capital Advisors, with participation from a syndicate of other...
You must be a Standard 1 Year member to access this content.
